Particularly, this study aimed to determine the unique in-vivo albumin modifications profile of HD patients, to evaluate its pro-inflammatory effects on endothelial cells and to correlate these effects to albumin reversible and/or irreversible modifications. This evidence concerns the gene ALB and Huntington disease.